Financials

Discussions Technicals Seasonals

6785 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Alar Pharmaceuticals, Inc. engages in the development of long-acting release drug products for CNS disorders and chronic diseases. It develops drugs for opioid use disorder, chronic pain, and major depressive disorder. The company was founded on September 23, 2016 and is headquartered in Taichung, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

6785 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company